A Shortened Diagnostic Interval and Its Associated Clinical Factors and Related Outcomes in Inflammatory Bowel Disease Patients from a Cohort Study in China
Runing Zhou,Xiyu Sun,Mingyue Guo,Huimin Zhang,Xuanfu Chen,Meixu Wu,Haozheng Liang,Xiaoyin Bai,Gechong Ruan,Hong Yang
DOI: https://doi.org/10.2147/jir.s434673
IF: 4.5
2024-01-19
Journal of Inflammation Research
Abstract:Runing Zhou, 1 Xiyu Sun, 2 Mingyue Guo, 1 Huimin Zhang, 1 Xuanfu Chen, 1 Meixu Wu, 1 Haozheng Liang, 1 Xiaoyin Bai, 1 Gechong Ruan, 1 Hong Yang 1 1 Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy Medical Sciences and Peking Union Medical College, Beijing, 100730, People's Republic of China; 2 Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy Medical Sciences and Peking Union Medical College, Beijing, 100730, People's Republic of China Correspondence: Hong Yang, Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Wangfujing Street, Beijing, 100730, People's Republic of China, Tel +86-10-69155014, Email Aim: The diagnosis of inflammatory bowel disease (IBD) worldwide is complicated and results in diagnostic delay. However, the diagnostic interval of IBD and the factors associated with diagnostic delay in patients in China have not been determined. Methods: We retrospectively analyzed clinical data of hospitalized IBD patients in Peking Union Medical College Hospital from January 1998 to January 2018. Patients were divided into non-delayed and delayed groups according to their diagnostic interval. Results: A total of 516 and 848 patients were confirmed to have Crohn's disease (CD) and ulcerative colitis (UC), respectively. The median diagnostic intervals were 6 and 20 months in patients with UC and CD, respectively ( P < 0.05). A decreasing trend in the diagnostic interval for IBD was observed over time, from 9 months to 1 month in UC patients and from 30 months to 3 months in CD patients. The longest diagnostic interval was 29.5 months in CD patients with first symptoms at the age of 51– 60 years and 12.5 months in UC patients at the age of 41– 50 years. In patients with CD, intestinal obstruction (OR=2.71), comorbid diabetes (OR=4.42), and appendectomy history (OR=2.18) were risk factors for diagnostic delay, whereas having fever as the first symptom may reduce its risk (OR=0.39). In patients with UC, the misdiagnosis of chronic enteritis (OR=2.10) was a risk factor for diagnostic delay. Conclusion: The diagnostic interval for IBD has decreased over the years. Some clinical manifestations, such as initial symptoms and age at symptom onset, may help to shorten this interval. Diseases such as tuberculosis and infectious enteritis should be considered during differentiation. Keywords: inflammatory bowel disease, diagnostic delay, China Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's disease (CD), is a relapsing chronic inflammatory disorder of the gastrointestinal tract. Its specific etiology is unknown but it possibly involves genetic, immunological, and environmental factors. 1 The diagnosis of IBD is a complicated task worldwide, and the number of factors contributing to this disease and possibly causing diagnostic delay (DD) in a considerable number of IBD patients. According to a summary by Gottfried et al from Austria, 2 the median diagnostic interval varied from 3 months to 7 years and from 1 month to 1 year in CD and UC patients, respectively. In China, IBD is not a common gastrointestinal disease and has atypical symptoms, physical signs or a lack of sufficient attention. The diagnosis of IBD relies on a combination of clinical, biochemical, stool, endoscopic, and cross-sectional imaging findings; histological investigations; and the exclusion of infectious enteritis. Follow-up for at least six months or one year is essential when the diagnosis is doubtful. A few diseases, such as intestinal tuberculosis (ITB), infectious enteritis, and Behçet's disease (BD), mimic the manifestations of IBD and are endemic in China, posing a major challenge in differential diagnosis. 2,3 Several studies have reported that DD worsens the prognosis of IBD patients. Two Korean studies revealed that DD increased not only the risk of intestinal surgery by 2.54-fold and 6.81-fold in CD and UC patients, respectively, but also the risk of intestinal stenosis or perianal fistula in CD patients. 4,5 Moreover, DD may delay the proper treatment of IBD patients, as some medications may have better efficacy in newly diagnosed patients. Therefore, identifying risk factors for DD at an early stage is important. As an emerging disease in China, IBD has a growing incidence trend, and several studies have reported notable differences in its clinical characteristics compared to West. 2 For example, there was a male predominance of CD in China, and less family clu -Abstract Truncated-
immunology